DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.
暂无分享,去创建一个
K. Tarte | T. Fest | L. Dupré | F. Uhel | P. Ruminy | Rada Amin | T. Lamy | C. Pangault | F. Mourcin | T. Marchand | Marion Guirriec
[1] G. Packham,et al. Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells. , 2015, Blood.
[2] C. Buske,et al. Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma. , 2015, Blood.
[3] Karin Tarte,et al. CD10 delineates a subset of human IL-4 producing follicular helper T cells involved in the survival of follicular lymphoma B cells. , 2015, Blood.
[4] J. Zikherman,et al. Cutting Edge: An In Vivo Reporter Reveals Active B Cell Receptor Signaling in the Germinal Center , 2015, The Journal of Immunology.
[5] B. Nadel,et al. Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites , 2015, Haematologica.
[6] B. Nadel,et al. Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. , 2014, The Journal of clinical investigation.
[7] J. Tao,et al. The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies , 2014, Oncogene.
[8] W. Klapper,et al. Genomic and epigenomic co-evolution in follicular lymphomas , 2014, Leukemia.
[9] R. Gascoyne,et al. The tumour microenvironment in B cell lymphomas , 2014, Nature Reviews Cancer.
[10] B. Nadel,et al. Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? , 2014, Blood.
[11] P. Dunbar,et al. Mapping the Distinctive Populations of Lymphatic Endothelial Cells in Different Zones of Human Lymph Nodes , 2014, PloS one.
[12] K. Tarte,et al. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity. , 2014, Seminars in cancer biology.
[13] M. Cogné,et al. AID-induced remodeling of immunoglobulin genes and B cell fate , 2013, Oncotarget.
[14] J. Garcia-Vallejo,et al. The physiological role of DC-SIGN: a tale of mice and men. , 2013, Trends in immunology.
[15] A. Rosenwald,et al. Somatic hypermutation analysis in follicular lymphoma provides evidence suggesting bidirectional cell migration between lymph node and bone marrow during disease progression and relapse , 2013, Haematologica.
[16] T. Rothstein,et al. IL-4 Upregulates Igα and Igβ Protein, Resulting in Augmented IgM Maturation and B Cell Receptor–Triggered B Cell Activation , 2013, The Journal of Immunology.
[17] S. Amigorena,et al. Similar antigen cross-presentation capacity and phagocytic functions in all freshly isolated human lymphoid organ–resident dendritic cells , 2013, The Journal of experimental medicine.
[18] Jinsong Wei,et al. Nonstereotyped Lymphoma B Cell Receptors Recognize Vimentin as a Shared Autoantigen , 2013, The Journal of Immunology.
[19] L. Staudt,et al. Targeting pathological B cell receptor signalling in lymphoid malignancies , 2013, Nature Reviews Drug Discovery.
[20] Ash A. Alizadeh,et al. Self-antigen recognition by follicular lymphoma B-cell receptors. , 2012, Blood.
[21] K. Tarte,et al. Stromal Cell Contribution to Human Follicular Lymphoma Pathogenesis , 2012, Front. Immun..
[22] M. Shlomchik,et al. B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity , 2012, Science.
[23] K. Tarte,et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells , 2012, Leukemia.
[24] K. Tarte,et al. Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. , 2011, Blood.
[25] K. Tarte,et al. Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling , 2012, Leukemia.
[26] R. Maul,et al. Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response , 2011, Science.
[27] A. Puig-Kröger,et al. Dendritic Cell-Specific ICAM-3–Grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages Is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10 , 2011, The Journal of Immunology.
[28] Michal Barak,et al. Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses. , 2010, International immunology.
[29] A. Ghaemmaghami,et al. Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins , 2010, Proceedings of the National Academy of Sciences.
[30] Kelly J. Morris,et al. Brief Report Results and Discussion , 2022 .
[31] Ash A. Alizadeh,et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.
[32] J. D. Vos,et al. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axis , 2009, Leukemia.
[33] F. Delbos,et al. Multiple layers of B cell memory with different effector functions , 2009, Nature Immunology.
[34] L. Martínez-Pomares,et al. Influence of the mannose receptor in host immune responses. , 2009, Immunobiology.
[35] J. Cerhan,et al. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. , 2009, Cancer research.
[36] C. Copie-Bergman,et al. The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages , 2009, Leukemia.
[37] E. Jaffe,et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. , 2008, Blood.
[38] J. Radford,et al. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. , 2008, Blood.
[39] W. Fridman,et al. Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation , 2007, Journal of leukocyte biology.
[40] F. Jardin,et al. Recurrent disruption of the Iμ splice donor site in t(14;18) positive lymphomas : A potential molecular basis for aberrant downstream class switch recombination , 2007 .
[41] Stephen W. Martin,et al. Enhancement and suppression of signaling by the conserved tail of IgG memory–type B cell antigen receptors , 2007, The Journal of experimental medicine.
[42] R. Dwek,et al. Human Follicular Lymphoma Cells Contain Oligomannose Glycans in the Antigen-binding Site of the B-cell Receptor* , 2007, Journal of Biological Chemistry.
[43] F. Jardin,et al. Recurrent disruption of the Imu splice donor site in t(14;18) positive lymphomas: a potential molecular basis for aberrant downstream class switch recombination. , 2007, Genes, chromosomes & cancer.
[44] Jonathan M Irish,et al. Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells. , 2006, Blood.
[45] Karey Shumansky,et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). , 2005, Blood.
[46] L. Staudt,et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. , 2004, The New England journal of medicine.
[47] T. Hamblin,et al. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. , 2002, Blood.
[48] M. Dyer,et al. DNA fiber fluorescence in situ hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant CH gene rearrangements in follicle center-cell lymphoma. , 1998, Blood.
[49] P. Stahl,et al. Mannose receptor. , 1992, International review of cytology.
[50] R. Warnke,et al. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. , 1985, The New England journal of medicine.
[51] M. Raffeld,et al. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma. Escape from detection by anti-idiotype. , 1985, The New England journal of medicine.